These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 29176524)

  • 1. NOVEL CASE OF CLOSTRIDIUM PERFRINGENS ENDOPHTHALMITIS AFTER ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR INJECTION.
    Kadaba VR; Menon J
    Retin Cases Brief Rep; 2020; 14(2):181-182. PubMed ID: 29176524
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bilateral endophthalmitis following bilateral same-day anti-VEGF injections.
    Sepetis AE; Clarke B; Gupta B
    Acta Ophthalmol; 2021 Feb; 99(1):e131-e133. PubMed ID: 32533656
    [No Abstract]   [Full Text] [Related]  

  • 3. Endophthalmitis after Intravitreal Injection of Vascular Endothelial Growth Factor Inhibitors: Management and Visual Outcomes.
    Xu K; Chin EK; Bennett SR; Williams DF; Ryan EH; Dev S; Mittra RA; Quiram PA; Davies JB; Parke DW; Johnson JB; Cantrill HL; Almeida DRP
    Ophthalmology; 2018 Aug; 125(8):1279-1286. PubMed ID: 29477689
    [TBL] [Abstract][Full Text] [Related]  

  • 4. COMPARATIVE RISK OF ENDOPHTHALMITIS AFTER INTRAVITREAL INJECTION WITH BEVACIZUMAB, AFLIBERCEPT, AND RANIBIZUMAB.
    Bavinger JC; Yu Y; VanderBeek BL
    Retina; 2019 Oct; 39(10):2004-2011. PubMed ID: 30312260
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Leuconostoc as a Cause of Endophthalmitis Post-intravitreal Injection of Ranibizumab.
    Damasceno NP; Horowitz SA; Damasceno EF
    Ocul Immunol Inflamm; 2016; 24(1):118-9. PubMed ID: 24749654
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Changes in Management Based on Vitreous Culture in Endophthalmitis After Intravitreal Anti-vascular Endothelial Growth Factor Injection.
    Patel SN; Storey PP; Pancholy M; Obeid A; Wibbelsman TD; Levin H; Hsu J; Garg SJ; Dunn JP; Vander JF
    Am J Ophthalmol; 2019 Nov; 207():224-231. PubMed ID: 31201794
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endophthalmitis after intravitreal vascular [corrected] endothelial growth factor antagonists: a six-year experience at a university referral center.
    Moshfeghi AA; Rosenfeld PJ; Flynn HW; Schwartz SG; Davis JL; Murray TG; Smiddy WE; Berrocal AM; Dubovy SR; Lee WH; Albini TA; Lalwani GA; Kovach JL; Puliafito CA
    Retina; 2011 Apr; 31(4):662-8. PubMed ID: 21836400
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incidence of Endophthalmitis after Intravitreal Anti-vascular Endothelial Growth Factor: Experience in Saudi Arabia.
    Al-Rashaed S; Alsulaiman SM; Alrushood AA; Almasaud J; Arevalo JF
    Middle East Afr J Ophthalmol; 2016; 23(1):60-3. PubMed ID: 26957840
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Outcomes and risk factors associated with endophthalmitis after intravitreal injection of anti-vascular endothelial growth factor agents.
    Shah CP; Garg SJ; Vander JF; Brown GC; Kaiser RS; Haller JA;
    Ophthalmology; 2011 Oct; 118(10):2028-34. PubMed ID: 21705087
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CLOSTRIDIUM PERFRINGENS PANOPHTHALMITIS AFTER INTRAVITREAL ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR INJECTION.
    Kancherla S; Ross A; Stefko ST; Martel JN
    Retin Cases Brief Rep; 2020; 14(2):192-194. PubMed ID: 29155693
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endophthalmitis following Intravitreal Anti-Vascular Endothelial Growth Factor Therapy: Changes in Incidence and Outcomes over a 9-Year Period.
    Pancholy M; Storey PP; Levin HJ; Obeid A; Patel SN; Kuley B; Hsu J; Spirn MJ; Fineman M; Klufas MA; Gupta O; Ho AC; Garg SJ
    Curr Eye Res; 2021 Sep; 46(9):1370-1377. PubMed ID: 33522314
    [No Abstract]   [Full Text] [Related]  

  • 12. Evaluation of the incidence of endophthalmitis after intravitreal injection of anti-vascular endothelial growth factor.
    Inoue M; Kobayakawa S; Sotozono C; Komori H; Tanaka K; Suda Y; Matsushima H; Kinoshita S; Senoo T; Tochikubo T; Kadonosono K
    Ophthalmologica; 2011; 226(3):145-50. PubMed ID: 21811052
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Meta-analysis of endophthalmitis after intravitreal injection of anti-vascular endothelial growth factor agents: causative organisms and possible prevention strategies.
    McCannel CA
    Retina; 2011 Apr; 31(4):654-61. PubMed ID: 21330939
    [TBL] [Abstract][Full Text] [Related]  

  • 14. LOW ENDOPHTHALMITIS RATES AFTER INTRAVITREAL ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR INJECTIONS IN AN OPERATION ROOM: A Retrospective Multicenter Study.
    Freiberg FJ; Brynskov T; Munk MR; Sørensen TL; Wolf S; Wirth MA; Becker M; Michels S
    Retina; 2017 Dec; 37(12):2341-2346. PubMed ID: 28099318
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Complications of subspecialty ophthalmic care: endophthalmitis after intravitreal injections of anti-vascular endothelial growth factor medications.
    Haddock LJ; Ramsey DJ; Young LH
    Semin Ophthalmol; 2014; 29(5-6):257-62. PubMed ID: 25325851
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clostridium perfringens endophthalmitis after penetrating keratoplasty with contaminated corneal allografts: a case series.
    Hou JH; Tannan A; Rubenstein JB; Lopez OI; McCoy K; Epstein RJ; Grostern RJ; Sugar J
    Cornea; 2015 Jan; 34(1):23-7. PubMed ID: 25393093
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clostridium sordellii endophthalmitis after suture removal from a corneal transplant.
    Zink JM; Singh-Parikshak R; Sugar A; Johnson MW
    Cornea; 2004 Jul; 23(5):522-3. PubMed ID: 15220740
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Severe
    Salceanu SO; Levy S; Cunningham R; Frimpong-Ansah K
    Indian J Ophthalmol; 2017 Nov; 65(11):1249-1251. PubMed ID: 29133669
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pars plana vitrectomy in the management of patients diagnosed with endophthalmitis following intravitreal anti-vascular endothelial growth factor injection.
    Chaudhary KM; Romero JM; Ezon I; Fastenberg DM; Deramo VA
    Retina; 2013; 33(7):1407-16. PubMed ID: 23492945
    [TBL] [Abstract][Full Text] [Related]  

  • 20. LONG-TERM VISUAL OUTCOMES AND CLINICAL FEATURES AFTER ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR INJECTION-RELATED ENDOPHTHALMITIS.
    Rayess N; Obeid A; Storey PP; Juliano J; Rahimy E; Moshfeghi AA; Garg S; Hsu J
    Retina; 2019 Nov; 39(11):2070-2076. PubMed ID: 30157114
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.